We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

By LabMedica International staff writers
Posted on 29 Sep 2023
Print article
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi, UAE) on October 7-8, 2023, at the Grand Hyatt Hotel in Dubai, UAE. At AACC Middle East 2023, attendees will have the chance to engage with industry leaders, healthcare experts, and academics in the field of clinical pathology and laboratory medicine. The exhibit area will attract over 1,000 attendees and feature leading companies in the In Vitro Diagnostics (IVD) sector.

The two-day conference will focus on emerging topics particularly relevant to the Middle East region, while the exposition will showcase the most recent advancements in various aspects such as mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing, point-of-care technologies, and automation. The conference agenda includes educational programs and a dynamic exposition, featuring the newest trends in clinical lab medicine, diagnostics, and best practices from experts. Topics to be discussed range from infectious diseases and big data analytics to prenatal emerging technologies, along with core laboratory practices like sample transportation, lab management, and quality assurance. Each session will feature knowledgeable speakers from AACC's scientific leadership. The event offers a unique opportunity for attendees to network with peers and experts, both from the United States and the Middle East, to exchange insights on the latest in laboratory medicine.

AACC Middle East is tailored for a diverse audience including physicians, lab supervisors, lab directors and their assistants, lab managers, medical technologists, pathologists, immunologists, fellows, residents, and those in training, among other healthcare professionals with an interest in laboratory medicine. Participants will have the chance to explore the latest research and technologies in the field. They can also gain insights into effective lab management strategies to streamline workflows, improve testing accuracy, and subsequently enhance treatment decisions and patient outcomes. Moreover, attendees will also learn how to adopt modern lab testing methods and technology, along with data-driven practices for preanalytical, analytical, and postanalytical phases of sample processing.

Related Links:
ADLM 
Life Dx 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.